tiprankstipranks
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market
8F8
SynAct Pharma AB
RESEARCH TOOLSreports
Want to see DE:8F8 full AI Analyst Report?

SynAct Pharma AB (8F8) Stock News & Sentiment

0 Followers
SynAct Pharma to Showcase Lead Inflammation Drug Ahead of Key Rheumatoid Arthritis Data
Premium
Company Announcements
SynAct Pharma to Showcase Lead Inflammation Drug Ahead of Key Rheumatoid Arthritis Data
4d ago
SynAct Pharma convenes AGM and opts to retain earnings
Premium
Company Announcements
SynAct Pharma convenes AGM and opts to retain earnings
16d ago
SynAct Pharma Finishes Phase 2b Dosing in Rheumatoid Arthritis Study
Premium
Company Announcements
SynAct Pharma Finishes Phase 2b Dosing in Rheumatoid Arthritis Study
17d ago
SynAct Pharma Targets New Partnerships Ahead of Key Resomelagon Data
Premium
Company Announcements
SynAct Pharma Targets New Partnerships Ahead of Key Resomelagon Data
18d ago
SynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
Premium
Company Announcements
SynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
29d ago
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
Premium
Company Announcements
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
1M ago
SynAct Pharma Raises Share Capital Through Directed Issue
Premium
Company Announcements
SynAct Pharma Raises Share Capital Through Directed Issue
2M ago
More DE:8F8 News >

8F8 News on the Web

SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
TipRanks News
Bullish
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
TipRanks News
Bullish
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
TipRanks News
Bullish
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
TipRanks News
Bullish
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
TipRanks News
Bullish
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
TipRanks News
Bullish
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
TipRanks News
Neutral
SynAct Pharma AB Announces Increase in Shares and Votes
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:8F8
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:8F8’s Media Buzz Sentiment?
1 articles about DE:8F8 were published this week. In an average week, 1 articles are published.
    What is DE:8F8’s weekly average amount of articles?
    In an average week, 1 articles about DE:8F8 are published.
      What is DE:8F8’s News Sentiment?
      100% of articles about DE:8F8 were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        JUNSJupiter Neurosciences, Inc.
        Showing the stocks with the most bullish news sentiment over the past week